chr19-45406703-G-A
Variant summary
Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_012099.3(POLR1G):c.7G>A(p.Glu3Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000162 in 1,538,912 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_012099.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 0 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
POLR1G | ENST00000309424.8 | c.7G>A | p.Glu3Lys | missense_variant | Exon 1 of 3 | 1 | NM_012099.3 | ENSP00000310966.3 | ||
POLR1G | ENST00000589804.1 | c.7G>A | p.Glu3Lys | missense_variant | Exon 1 of 3 | 1 | ENSP00000465099.1 | |||
POLR1G | ENST00000590794.1 | c.4G>A | p.Glu2Lys | missense_variant | Exon 1 of 2 | 5 | ENSP00000466503.1 | |||
POLR1G | ENST00000592852 | c.-903G>A | 5_prime_UTR_variant | Exon 1 of 2 | 2 | ENSP00000467771.1 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152154Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.00 AC: 0AN: 142414 AF XY: 0.00
GnomAD4 exome AF: 0.0000159 AC: 22AN: 1386758Hom.: 0 Cov.: 31 AF XY: 0.0000146 AC XY: 10AN XY: 684352 show subpopulations
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152154Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74334 show subpopulations
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.7G>A (p.E3K) alteration is located in exon 1 (coding exon 1) of the CD3EAP gene. This alteration results from a G to A substitution at nucleotide position 7, causing the glutamic acid (E) at amino acid position 3 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at